Phase II study of sunitinib malate (SU11248) in bevacizumab-refractory metastatic renal cell carcinoma (MRCC)
Conference Paper
Full Text
Duke Authors
Cited Authors
- Rini, BI; George, DJ; Michaelson, MD; Rosenberg, JE; Bukowski, RM; Sosman, JA; Stadler, WM; Margolin, K; Hutson, TE; Baum, CM
Published Date
- January 1, 2006
Published In
Volume / Issue
- 17 /
Start / End Page
- 144 - 144
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 0923-7534
Conference Name
- 30th Congress of the European-Society-for-Medical-Oncology
Conference Location
- Istanbul, TURKEY
Conference Start Date
- September 29, 2006
Conference End Date
- October 3, 2006